- Home
- SBSW vs ARWR Comparison
SBSW vs ARWR Comparison
Compare SBSW & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBSW | ARWR |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.6B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | SBSW | ARWR |
|---|---|---|
| Price | $15.68 | $70.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $6.90 | ★ $63.70 |
| AVG Volume (30 Days) | ★ 5.0M | 3.0M |
| Earning Date | 08-28-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,290,132,787.00 | $829,448,000.00 |
| Revenue This Year | $14.58 | N/A |
| Revenue Next Year | $18.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.11 | ★ 23258.15 |
| 52 Week Low | $3.05 | $9.57 |
| 52 Week High | $15.43 | $72.36 |
Technical Indicators
Market Signals| Indicator | SBSW | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 76.71 | 70.59 |
| Support Level | $14.76 | $68.00 |
| Resistance Level | $15.43 | $71.30 |
| Average True Range (ATR) | 0.55 | 3.77 |
| MACD | 0.20 | -0.53 |
| Stochastic Oscillator | 96.51 | 83.42 |
Price Performance
Historical ComparisonAbout SBSW D/B/A Sibanye-Stillwater Limited ADS
Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.